Cards (4)

    • The innermost layer of the heart is the endothelium
    • Endothelium lining the cardiac chambers is continuous with the endothelium of all blood vessels in the body and is composed of squamous epithelial cells
    • The cardiac endothelium provides a friction free interface between the walls of the chambers and the blood contained within them and moving through them
    • This layer just like endothelial cells lining blood vessels also secretes prostacyclin, which repels platelets and prevents platelet adhesion to the walls of the cardiac chambers and vessels
  • Why is it important to stop platelets forming within the cardiac chambers and vessels?
    • Preventing Blood Clots (Thrombosis)
    • Platelets play a vital role in blood clot formation, but if they aggregate unnecessarily inside heart or vessels, thrombi (clots) that obstruct blood flow can form
    • Reducing the Risk of Stroke and Embolism
    • If a thrombus forms in the left atrium/ventricle, it can break off and go to the brain, causing an ischemic stroke.
    • This is dangerous in conditions like atrial fibrillation, where irregular heartbeats can lead to blood pooling in the atria, increasing clot risk
  • Why is it important to stop platelets forming within the cardiac chambers and vessels?
    • Preventing Heart Attacks (Myocardial Infarction)
    • Platelet aggregation in the coronary arteries can block blood supply to the heart muscle, leading to a heart attack (myocardial infarction)
    • This occurs when a plaque ruptures in coronary artery disease, triggering platelet activation and clot formation
    • Avoiding Pulmonary Embolism
    • thrombus in the right atrium or right ventricle can travel to the lungs, causing a pulmonary embolism
    • This can impair oxygen exchange, leading to respiratory failure and death
  • Why is it important to stop platelets forming within the cardiac chambers and vessels?
    • Maintaining Healthy Circulation
    • Platelet overactivity can lead to hypercoagulability, increasing the risk of widespread clotting (e.g., deep vein thrombosis (DVT) or disseminated intravascular coagulation (DIC)).
    • Antiplatelet medications (e.g., aspirin, clopidogrel) and anticoagulants (e.g., warfarin, heparin) are often prescribed to prevent clot formation in high-risk individuals.